Elanco Animal Health Inc.
ELAN • NYSE
Elanco Animal Health Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Jeffrey N. Simmons, with a market cap of $11.5B.
CEOJeffrey N. Simmons
Next Earnings
Upcoming earnings announcement for Elanco Animal Health Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.35
Revenue Estimate
$1.3B
Earnings History
Past 12 earnings reports for Elanco Animal Health Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.13Est: $0.11 | +18.2% | $1.1BEst: $1.1B | +4.7% |  10-K |
| Nov 5, 2025 | Q3 2025 | $0.19Est: $0.13 | +46.2% | $1.1BEst: $1.1B | +4.2% | 10-Q |
| Aug 7, 2025 | Q2 2025 | $0.26Est: $0.20 | +30.0% | $1.2BEst: $1.2B | +4.4% | 10-Q |
| May 7, 2025 | Q1 2025 | $0.37Est: $0.31 | +19.4% | $1.2BEst: $1.2B | -1.4% | 10-Q |
| Feb 25, 2025 | Q4 2024 | $0.14Est: $0.15 | -6.7% | $1.0BEst: $1.0B | +1.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.13Est: $0.12 | +8.3% | $1.0BEst: $1.0B | 0.0% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.30Est: $0.24 | +25.0% | $1.0BEst: $1.2B | -12.1% | 10-Q |
| May 8, 2024 | Q1 2024 | $0.34Est: $0.27 | +25.9% | $1.2BEst: $1.2B | +3.0% | 10-Q |
| Feb 26, 2024 | Q4 2023 | $0.08Est: $0.11 | -27.3% | $1.0BEst: $1.0B | +3.5% | 10-K |
| Nov 7, 2023 | Q3 2023 | $0.18Est: $0.12 | +50.0% | $1.1BEst: $1.0B | +2.7% | — |
| Aug 7, 2023 | Q2 2023 | $0.18Est: $0.05 | +260.0% | $1.1BEst: $1.0B | +2.0% | 10-Q |
| May 9, 2023 | Q1 2023 | $0.45Est: $0.29 | +55.2% | $1.3BEst: $1.2B | +6.5% | — |